文献速递区域麻醉与超声疼痛医学

静脉右美托咪定联合地塞米松对四联神经阻滞镇痛时长的影响

Total knee arthroplasty under quadruple nerve block with ropivacaine 0.32%: effect of addition of intravenous dexmedetomidine to intravenous dexamethasone on analgesic duration.
PubMed 文献 · Reg Anesth Pain Med · 2020-10-21

这项双盲随机对照试验纳入90例全膝关节置换术患者,均接受70 mL 0.32%罗哌卡因四联神经阻滞及静脉地塞米松10 mg,随机加用静脉右美托咪定2 µg/kg或安慰剂。结果显示两组首次镇痛请求时间无差异,右美托咪定未延长镇痛时长,且与心动过缓、低血压和恢复室停留延长相关。

要点

  • 静脉右美托咪定2 µg/kg不延长0.32%罗哌卡因四联神经阻滞的镇痛时长。
  • 右美托咪定组心动过缓、低血压及恢复室停留时间延长。
  • 在已使用静脉地塞米松的多模式镇痛中,加用右美托咪定无额外获益。

核心结论

  • 在静脉地塞米松基础上加用静脉右美托咪定2 µg/kg不延长全膝关节置换术四联神经阻滞的镇痛时长。

研究设计与样本

  • 双盲随机对照试验,前瞻性纳入90例拟行全膝关节置换术的患者,随机1:1接受静脉右美托咪定2 µg/kg或安慰剂。

主要发现

  • 首次镇痛请求时间的Kaplan-Meier曲线两组相似(log-rank检验 p=0.27)。
  • 安慰剂组中位镇痛时长1575 min(IQR 1211-1952),右美托咪定组1470 min(IQR 1263-1700),p=0.56。
  • 48小时累积羟考酮消耗量安慰剂组20 mg(10-30),右美托咪定组30 mg(20-40),p=0.14。
  • 术后次日可行走患者比例安慰剂组93%,右美托咪定组89%,p=0.46。
  • 静脉右美托咪定与心动过缓、低血压及恢复室停留延长相关(所有比较p<0.05)。

关键数值与推荐

  • 四联神经阻滞包括坐骨神经、股神经、闭孔神经和股外侧皮神经阻滞,使用70 mL 0.32%罗哌卡因。
  • 所有患者接受全身地塞米松10 mg。
  • 主要终点为首次请求补救镇痛(羟考酮)的时间。

临床怎么用

  • 在全膝关节置换术多模式镇痛方案中,静脉地塞米松已使用时,加用静脉右美托咪定2 µg/kg不推荐用于延长四联神经阻滞镇痛时长。
  • 需注意静脉右美托咪定相关的心动过缓、低血压及恢复室停留延长风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Peripheral nerve blocks reduce postoperative pain and enhance recovery after total knee arthroplasty (TKA). This study aims to assess the benefits of addition of intravenous dexmedetomidine (DexM) to intravenous dexamethasone on the analgesic duration of quadruple nerve blocks. METHODS: This double-blind, randomized, controlled trial prospectively enrolled 90 patients scheduled for TKA under quadruple nerve blocks (sciatic, femoral, obturator, and lateral femoral cutaneous nerves blocks) with 70 mL, 0.32% ropivacaine. All patients received systemic dexamethasone 10 mg. Patients were randomized to receive DexM (2 µg/kg, intravenous) or placebo (1:1 ratio). The primary endpoint was the duration of analgesia defined as the time to first request for rescue analgesia (oxycodone). RESULTS: Kaplan-Meier curves for the first analgesic request were similar between groups (log-rank test; p=0.27). Median (IQR) duration of analgesia was similar between placebo (1575 min (1211-1952)) and DexM (1470 min (1263-1700)) groups (p=0.56). Cumulative consumption of oxycodone at the 48th hour was 20 mg (10-30) and 30 mg (20-40) in placebo and DexM groups, respectively (p=0.14). The day after surgery, 93% and 89% of patients were able to walk in placebo and DexM groups, respectively (p=0.46). Intravenous DexM was associated with bradycardia, hypotension and longer recovery room stay (p<0.05 for all comparisons). CONCLUSIONS: In a multimodal analgesic regimen, addition of systemic DexM (2 µg/kg) to systemic dexamethasone does not prolong the analgesic duration of quadruple nerve block with ropivacaine 0.32% after TKA. TRIAL REGISTRATION NUMBER: NCT03834129.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Chassery C, Marty P, Rontes O, et al. Total knee arthroplasty under quadruple nerve block with ropivacaine 0.32%: effect of addition of intravenous dexmedetomidine to intravenous dexamethasone on analgesic duration. Reg Anesth Pain Med. 2020. PMID: 33087480. doi:10.1136/rapm-2020-101749

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。